← Back to Search

Intervention for Abdominal Obesity

N/A
Waitlist Available
Led By Fang-yu Chou, PhD
Research Sponsored by San Francisco State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline daily physical activity at 3 months and 6 months
Awards & highlights

Summary

This project examines the feasibility of a smartphone-based intervention to reduce obesity and breast cancer risk among Chinese American women in San Francisco. The proposed intervention is to use the mobile application and an activity tracker device to promote a healthier lifestyle and physical activity. Ultimately, the findings will advance the NIH mission of enhancing health promotion and disease prevention.

Eligible Conditions
  • Abdominal Obesity
  • Cancer Prevention

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline breast cancer screening knowledge score at 3 months and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline breast cancer screening knowledge score at 3 months and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
breast cancer knowledge and attitudes
waist circumference
Secondary outcome measures
C-reactive protein
Hemoglobin A1C
Lipid panel
+5 more
Other outcome measures
Frequency of accessing the 12 educational modules
Number of uses of the tracking app

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
1. . Daily use of a Fitbit Alta HRTM to identify behavior patterns. 2. 12 weekly SCOPP-CW educational modules delivered via WeChat. 3. 6 bi-weekly WeChat tailored messages based on based on the participant's tracker information, personal goals, and preferences
Group II: ControlActive Control1 Intervention
1. . Daily use of a Fitbit Alta HRTM to identify behavior patterns. 2. 12 weekly non-tailored educational modules on general health topics delivered via WeChat.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SCOPP-CW
2019
N/A
~20

Find a Location

Who is running the clinical trial?

San Francisco State UniversityLead Sponsor
11 Previous Clinical Trials
2,439 Total Patients Enrolled
University of California, San FranciscoOTHER
2,551 Previous Clinical Trials
15,257,868 Total Patients Enrolled
Fang-yu Chou, PhDPrincipal InvestigatorSan Francisco State University
~3 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top